Results 271 to 280 of about 2,811,792 (409)

Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema. [PDF]

Clin Transl Allergy
Dubrall D, Branding NL, Mathey CM, Weber AM, Steffens M, Below M, Schmid M, Wedi B, Wieczorek D, Amann PM, Löffler H, Koch L, Schöffl C, Dickel H, Ganjuur N, Hornung T, Buhl T, Aygören-Pürsün E, Wurpts G, Greve J, Nöthen MM, Forstner AJ, Sachs B.   +22 more
europepmc   +1 more source

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertensive African Americans [PDF]

, 2003
P NARAYAN
openalex   +1 more source

Prognostic impact of iron deficiency in new‐onset chronic heart failure: Danish Heart Failure Registry insights

ESC Heart Failure, Volume 12, Issue 2, Page 1346-1357, April 2025.
Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl, Tor Biering‐Sørensen, Morten Lock Hansen, Mariam Elmegaard Malik, Nina Nouhravesh, Charlotte Anderrson, Morten Schou, Gunnar Gislason   +12 more
wiley   +1 more source

Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor. [PDF]

Card Fail Rev
Iacoviello M, Maria Sarullo F, Bilato C, Correale M, Di Gesaro G, Driussi M, Passantino A, Villani A, Di Lenarda A.   +8 more
europepmc   +1 more source

Angiotensin AT ₂ Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension

, 2010
Luis C. Matavelli, Jiqian Huang, Helmy M. Siragy   +2 more
openalex   +2 more sources

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]

Biomed Rep
Rampengan DDCH, Surya SC, Tjandra KC, Lele JAJMN, Rampengan SH, Kadariswantiningsih IN, Idrisov B, Idrisova A, Empitu MA.   +8 more
europepmc   +1 more source

Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease

, 2014
Ping-Min Chen, Tai‐Shuan Lai, Ping‐Yu Chen, Chun‐Fu Lai, Vin‐Cent Wu, Wen‐Chih Chiang, Yung‐Ming Chen, Kwan‐Dun Wu, Tun‐Jun Tsai   +8 more
openalex   +2 more sources

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew Robertson, Anam A. Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli, Neal K. Lakdawala   +10 more
wiley   +1 more source

Angiotensin-Receptor Blockers Prevent Vestibular Schwannoma-Associated Hearing Loss. [PDF]

Otol Neurotol
Early S, Brown A, Xu L, Stankovic KM.
europepmc   +1 more source